Presence or absence of a gallate moiety on catechins affects their cellular transport

Journal of Pharmacy and Pharmacology

Volumn 60, Issue 9, 2008, Pages 1189-1195

  Kadowaki, Masaaki ^a   Sugihara, Narumi ^a   Tagashira, Tomohiko ^a   Terao, Kazumi ^a   Furuno, Koji ^a  

^a FUKUYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; EPICATECHIN; EPICATECHIN GALLATE; GLYCOPROTEIN P; MITOXANTRONE; MULTIDRUG RESISTANCE PROTEIN 2; QUINIDINE; VERLUKAST;

ARTICLE; CELL TRANSPORT; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG STRUCTURE; DRUG TRANSPORT; EFFUSION; HUMAN; HUMAN CELL;

ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CACO-2 CELLS; CATECHIN; HUMANS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; P-GLYCOPROTEIN;

EID: 49749101998     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.60.9.0011     Document Type: Article

References (31)

1. Albermann, N., Schmitz-Winnenthal, F. H., Z'graggen, K., Volk, C., Hoffmann, M. M., Haefeli W. E., Weiss J. (2005) Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver. Biochem. Pharmacol. 70: 949-958
2. Artursson, P., Karlsson, J. (1991) Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun. 175: 880-885
3. Bodo, A., Bakos, E., Szeri, F., Varadi, A., Sarkadi, B. (2003) The role of multidrug transporters in drug availability, metabolism and toxicity. Toxicol. Lett. 140-141: 133-143
4. Donovan, J. L., Crespy, V., Manach, C., Morand, C., Besson, C., Scalbert, A., Remesy, C. (2001) Catechin is metabolized by both the small intestine and liver of rats. J. Nutr. 131: 1753-1757
5. Duffy, S. J., Vit, J. A., Holbrook, M., Swerdloff, P. L., Keaney, J. F. (2001) Effect of acute and chronic tea consumption on platelet aggregation in patients with coronary artery disease. Arterioscler. Thromb. Vasc. 21: 1084-1089
6. Jodoin, J., Demeule, M., Beliveau, R. (2002) Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols. Biochem. Biophys. Acta 1542: 149-159
7. Katiyar, S. K., Mukhtar, H. (1997) Tea antioxidants in cancer chemoprevention. J. Cell Biochem. Suppl. 27: 59-67
8. Kitagawa, S., Nabekura, T., Kamiyama, S. (2004) Inhibition of P-glycoprotein function by tea catechins in KB-C2 cells. J. Pharm. Pharmacol. 56: 1001-1005
9. Kitagawa, S., Nabekura, T., Kamiyama, S., Takahashi, T., Nakamura, Y., Kashiwada, Y., Ikeshiro, Y. (2005) Effects of alkyl gallates on P-glycoprotein function. Biochem. Pharmacol. 70: 1262-1266
10. Konishi, Y., Shimizu, M. (2003) Transepithelial transport of ferulic acid by monocarboxylic acid transporter in Caco-2 cell monolayers. Biosci. Biotechnol. Biochem. 67: 856-862
11. Koo, M. W. L., Cho, C. H. (2004) Pharmacological effects of green tea on the gastrointestinal system. Eur. J. Pharmacol. 500: 177-185
12. Kuhnle, G., Spencer, J. P., Schroeter, H., Shenoy, B., Debnam, E. S., Srai, S. K., Rice-Evans, C., Hahn, U. (2000) Epicatechin and catechin are O-methylated and glucuronidated in the small intestine. Biochem. Biophys. Res. Commun. 277: 507-512
13. Lechapt-Zalcman, E., Hurbain, I., Lacave, R., Commo, F., Urban, T., Antoine, M., Milleron, B., Bernudin, J. F. (1997) MDR1-Pgp 170 expression in human bronchus. Eur. Respir. J. 10: 1837-1843
14. Lee, M. J., Wang, Z. Y., Li, H., Chen, L., Sun, Y., Gobbo, S., Balentine, D. A., Yang, C. S. (1995) Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiol. Biomarkers Prev. 4: 393-399
15. Lowry, O. H., Rosebrough, N. J., Farr A, L., Randall, R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275
16. Maliepaard, M., Scheffer, G. L., Faneyte, I. F., van Gastelen, M. A., Pijnenborg, A. C., Schinkel, A. H., van De Vijver, M. J., Scheper, R. J., Schellens, J. H. (2001) Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res. 61: 3458-3464
17. Mei, Y., Qian, F., Wei, D., Liu, J. (2004) Reversal of cancer multidrug resistance by green tea polyphenols. J. Pharm. Pharmacol. 56: 1307-1314
18. Nakagawa, K., Okuda, S., Miyazawa, T. (1997) Dose-dependent incorporation of tea catechins, (-)-epigallocatechin-3-gallate and (-)-epigallocatechin, into human plasma. Biosci. Biotech. Bio-chem. 61: 1981-1985
19. Nakagawa, K., Ninomiya, M., Okubo, T., Aoi, N., Juneja, L.R., Kim, M., Yamanaka, K., Miyazawa, T. (1999) Tea catechin supplementation increases antioxidant capacity and prevents phospholipid hydroperoxidation in plasma of humans, J. Agric. Food Chem. 47: 3967-3973
20. Schwab, M., Eichelbaum, M., Fromm, M. F. (2003) Genetic polymorphisms of the human MDR1 drug transporter. Annu. Rev. Pharmacol. Toxicol. 43: 285-307
21. Sugihara, N., Toyama, K., Michihara, A., Akasaki, K., Tsuji, H., Furuno, K. (2006) Effect of benzo[a]pyrene on P-glycoprotein-mediated transport in Caco-2 cell monolayer. Toxicology 223: 156-165
22. Taipalensuu, J., Tomblom, H., Lindberg, G., Einarsson, C., Sjoqvist F., Melhus, H., Garberg, P., Sjostrom, B., Lundgren, B., Artursson, P. (2001) Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers. J. Pharmacol. Exp. Ther. 299: 164-170
23. Takano, M., Yumoto, R., Murakami, T. (2006) Expression and function of efflux drug transporters in the intestine. Pharmacol. Ther. 109:137-161
24. Tang, F., Ouyang, H., Yang J. Z., Borchardt, R. T. (2004) Bidirectional transport of rhodamine 123 and Hoechst 33342, fluorescence probes of the binding sites on P-glycoprotein, across MDCK-MDR1 cell monolayers. J. Pharm. Sci. 93: 1185-1194
25. Tatsumura, K., Kokuni, I., Ise M., Sugiyama, K., Yamamoto, M. (2002) Health science of tea: new possibility for physiological function. Scientific Societies Press, Japan, pp 52-64 (ISBN-4-7622-2991-1)
26. Vaidyanathan, J. B., Walle, T. (2001) Transport and metabolism of the tea flavonoid (-)-epicatechin by the human intestinal cell line Caco-2. Pharm Res. 18: 1420-1425
27. Vaidyanathan, J. B., Walle, T. (2002) Glucuronidation and sulfation of the tea flavonoid (-)-epicatechin by the human and rat enzymes. Drug. Metab. Dispos. 30: 897-903
28. Vaidyanathan, J. B., Walle, T. (2003) Cellular uptake and efflux of the tea flavonoid (-)-epicatechin-3-gallate in the human intestinal cell line Caco-2. J. Pharmacol. Exp. Ther. 307: 745-752
29. Young, J. F., Dragsted, L. O., Haraldsdottir, J., Daneshvar, B., Kall, M. A., Loft, S., Nilsson, L., Nielsen, S. E., Mayer, B., Skibsted, L. H., Huynh-Ba, T., Hermetter, A., Sandstrom, B. (2002) Green tea extract only affects markers of oxidative status postprandially: lasting antioxidant effect of flavonoid-free diet. Br. J. Nutr. 87: 343-355
30. Zhang, L., Zheng, Y., Chow, M. S. S., Zuo, Z. (2004a) Investigation of intestinal absorption and disposition of green tea catechins by Caco-2 monolayer model. Int. J. Pharm. 287: 1-12
31. Zhang, S., Yang, X., Morris, M. E. (2004b) Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport. Am. Soc. Pharmacol. Exp. Ther. 65: 1208-1216